pubmed-article:6141858 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0024117 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0035203 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0002164 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0017110 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0678640 | lld:lifeskim |
pubmed-article:6141858 | lifeskim:mentions | umls-concept:C0449774 | lld:lifeskim |
pubmed-article:6141858 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:6141858 | pubmed:dateCreated | 1984-4-12 | lld:pubmed |
pubmed-article:6141858 | pubmed:abstractText | Almitrine at a low dose of 100 mg orally significantly raises PaO2 and lowers PaCO2 in patients with chronic obstructive pulmonary disease, compared with placebo, when they were breathing air or 28% oxygen. The estimated ideal alveolar-arterial PO2 difference was less after almitrine compared with placebo, when patients were breathing either air or 28% oxygen. After almitrine overall ventilation breathing air increased by 10% but this did not reach statistical significance. During 28% oxygen breathing almitrine hardly altered overall ventilation but the inspiratory duty cycle (Ti/Ttot.) decreased and mean inspiratory flow rate (VT/Ti) increased compared with placebo. These changes were significant on a paired t-test (P less than 0.05). Changes in both volume and pattern of breathing may explain the improved gas exchange in the lung after almitrine. | lld:pubmed |
pubmed-article:6141858 | pubmed:language | eng | lld:pubmed |
pubmed-article:6141858 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6141858 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6141858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6141858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6141858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6141858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6141858 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6141858 | pubmed:month | Apr | lld:pubmed |
pubmed-article:6141858 | pubmed:issn | 0143-5221 | lld:pubmed |
pubmed-article:6141858 | pubmed:author | pubmed-author:NicholsC PCP | lld:pubmed |
pubmed-article:6141858 | pubmed:author | pubmed-author:HughesJ MJM | lld:pubmed |
pubmed-article:6141858 | pubmed:author | pubmed-author:StradlingJ... | lld:pubmed |
pubmed-article:6141858 | pubmed:author | pubmed-author:DaviesE EEE | lld:pubmed |
pubmed-article:6141858 | pubmed:author | pubmed-author:PrideN BNB | lld:pubmed |
pubmed-article:6141858 | pubmed:author | pubmed-author:CoverDD | lld:pubmed |
pubmed-article:6141858 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6141858 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:6141858 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6141858 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6141858 | pubmed:pagination | 435-42 | lld:pubmed |
pubmed-article:6141858 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:meshHeading | pubmed-meshheading:6141858-... | lld:pubmed |
pubmed-article:6141858 | pubmed:year | 1984 | lld:pubmed |
pubmed-article:6141858 | pubmed:articleTitle | The effects of oral almitrine on pattern of breathing and gas exchange in patients with chronic obstructive pulmonary disease. | lld:pubmed |
pubmed-article:6141858 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6141858 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:6141858 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6141858 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6141858 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6141858 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6141858 | lld:pubmed |